Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
The American Journal of Pathology|July 1, 1992
An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanomaU Fuchs, T Kivelä, P Summanen, et al.Journal of Clinical Microbiology|August 1, 1990
Selective medium for isolation of Bacteroides gracilisK Lee, E J Baron, P Summanen, et al.The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
Mechanisms of altered hemodynamic and metabolic responses to insulin in patients with insulin-dependent diabetes mellitus and autonomic dysfunctionS Mäkimattila, M Mäntysaari, A Schlenzka, et al.Journal of Clinical Microbiology|October 30, 2001
Phenotypic identification of Actinomyces and related species isolated from human sourcesN Sarkonen, E Könönen, P Summanen, et al.Regional Anesthesia and Pain Medicine|August 13, 1999
Retrobulbar/peribulbar block with 0.2% ropivacaine or 1% lidocaine for transscleral cyclophotocoagulation or retinal panphotocoagulationH Kallio, P Puska, P Summanen, et al.Ophthalmology|August 2, 2000
Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatmentS Eskelin, S Pyrhönen, P Summanen, et al.Cancer|March 26, 1999
Screening for metastatic malignant melanoma of the uvea revisitedS Eskelin, S Pyrhönen, P Summanen, et al.Retina (Philadelphia, Pa.)|January 1, 1996
Long-term follow-up of chronic Lyme neuroretinitisA Karma, T Stenborg, P Summanen, et al.Ophthalmic Surgery and Lasers|September 1, 1995
Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapyP Summanen, I Immonen, T Kivelä, et al.Ophthalmic Surgery|February 1, 1993
Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapyP Summanen, I Immonen, J Heikkonen, et al.Pageof 8